108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)
Titel:
108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)
Auteur:
Garassino, M.C. Mazieres, J. Reck, M. Chouaid, C. Bischoff, H. Reinmuth, N. Cove-Smith, L. Mansy, T. Cortinovis, D. Migliorino, M.R. Delmonte, A. Garcia Sánchez, J. Chara Velarde, L.E. Bernabe, R. Paz-Ares, L. Diaz Perez, I. Trunova, N. Foroutanpour, K. Faivre-Finn, C.